Pfizer, Flagship Pioneering to invest $100 mln in drug discovery

U.S. drugmaker Pfizer and venture firm Flagship Pioneering on Tuesday said they would invest $100 million together to develop up to 10 new potential drugs for areas including internal medicine, oncology, infectious diseases and immunology.

Read the full article here

Related Articles